Consortium Membership

Study location Study type Cases with DNA
Genotype-Phenotype Urothelial Cancer Study (html, pdf 26kb) Hospital-based 840
Spanish Bladder Cancer Study (html, pdf 31kb) Hospital-based 1,150
New England Bladder Cancer Study (html, pdf 95kb) Population-based 1,134
Nijmegen Bladder Cancer Study (html, pdf 30kb) Population-based 1,914
MD Anderson Bladder Cancer Study (html, pdf 161kb) Hospital-based 1,542
Los Angeles-Shanghai Bladder Cancer Study (html, pdf 51kb) Population-based 1,268
New Hampshire Bladder Cancer Study (html, pdf 14kb) Population-based 728
Leeds Bladder Cancer Study (html, pdf 162kb) Hospital-based 1,100
Torino Bladder Cancer (html, pdf 33kb) Hospital-based 422
Stockholm, Sweden   327
Seoul, Korea Hospital-based 241
Aarhus, Denmark   237
UCLA Molecular Epidemiology of Bladder Cancer (html, pdf 35kb) Hospital-based 170
North Carolina, USA Hospital-based 228
Akita and Kyoto, Japan Hospital-based 222
Lutherstadt Wittenberg Bladder Cancer Study (html, pdf 35kb) Hospital-based 216
Eastern European Bladder Cancer Study (html, pdf 33kb) Hospital based 214
Brescia Bladder Cancer Case-control Study (html, pdf 36kb) Hospital-based 200
Belgian Case-control Study on Bladder Cancer (html, pdf 36kb) Population-based 200
Oxford, UK   196
French Bladder Cancer Study (FBCS) (html, pdf 34kb) Hospital-based 195
Ankara, Turkey Hospital based 121
The South and East China case control study on Bladder Cancer. SEarCh (html, pdf 33kb) Hospital based 225/year
TOTAL (combined pdf of all studies 3.9mb)   13,090